Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxidation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102603716A details a novel titanium-catalyzed asymmetric oxidation for (S)-pantoprazole. Achieve 100% ee value with streamlined processing for reliable pharmaceutical intermediate supply.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Discover the novel preparation method for chloro-benzothiepin compounds. Enhanced purity, scalable synthesis, and cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN103788069B reveals advanced asymmetric oxidation for esomeprazole magnesium trihydrate. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Analysis of CN106380469A reveals a metal-free imidazolinone synthesis using molecular oxygen. This green method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102153433B details an aerobic oxidative synthesis of N-monosubstituted-alpha-carbonylamides. This method offers significant cost reduction in pharmaceutical intermediate manufacturing via mild, scalable conditions.
Solve isoquinolinone synthesis challenges with 92%+ yields, oxygen-based oxidation, and 5-step routes. Reduce costs and supply risks for pharma intermediates.
Discover how DDQ-catalyzed metal-free oxidation of propargyl alcohol solves supply chain risks and cost issues in ynone synthesis for pharmaceuticals.